Pneumococcal sequence type replacement among American Indian children: A comparison of pre- and routine-PCV7 eras

Vaccine

Volumn 30, Issue 13, 2012, Pages 2376-2381

  Scott, Jennifer R ^a   Hanage, William P ^b   Lipsitch, Marc ^c   Millar, Eugene V ^d   Moulton, Lawrence H ^a   Hinds, Jason ^e   Reid, Raymond ^a   Santosham, Mathuram ^a   O'Brien, Katherine L ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

MLST; Native Americans; PCV7; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

AMERICAN INDIAN; ARTICLE; BACTERIUM ISOLATION; CAPSULE SWITCHING; CHILD; COMPARATIVE STUDY; DRUG EFFICACY; HUMAN; IMMUNOSURVEILLANCE; MICROARRAY ANALYSIS; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; VACCINATION; VIRUS CARRIER;

ARIZONA; CARRIER STATE; CHILD; CHILD, PRESCHOOL; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; INFANT; MULTILOCUS SEQUENCE TYPING; NEW MEXICO; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84857785626     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.004     Document Type: Article

References (36)

1. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente vaccine study center group. Pediatr Infect Dis J 2000, 19(March (3)):187-195.
2. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001, 344(February (6)):403-409.
3. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201(January (1)):32-41.
4. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348(May (18)):1737-1746.
5. Park S.Y., Moore M.R., Bruden D.L., Hyde T.B., Reasonover A.L., Harker-Jones M., et al. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J 2008, 27(April (4)):335-340.
6. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124(July (1)):e1-e11.
7. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. Epub 2011 Apr 12. Corrected proof forthcoming.
8. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998, 95(March (6)):3140-3145.
9. Enright M.C., Spratt B.G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998, 144(November):3049-3060.
10. Beall B., McEllistrem M.C., Gertz R.E., Wedel S., Boxrud D.J., Gonzalez A.L., et al. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 2006, 44(March (3)):999-1017.
11. Pelton S.I., Huot H., Finkelstein J.A., Bishop C.J., Hsu K.K., Kellenberg J., et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007, 26(June (6)):468-472.
12. Hanage W.P., Huang S.S., Lipsitch M., Bishop C.J., Godoy D., Pelton S.I., et al. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis 2007, 195(February (3)):347-352.
13. Lipsitch M., O'Neill K., Cordy D., Bugalter B., Trzcinski K., Thompson C.M., et al. Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine. J Infect Dis 2007, 196(October (8)):1221-1227.
14. O'Brien K.L., Shaw J., Weatherholtz R., Reid R., Watt J., Croll J., et al. Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996. Am J Epidemiol 2004, 160(August (3)):270-278.
15. Millar E.V., O'Brien K.L., Zell E.R., Bronsdon M.A., Reid R., Santosham M. Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache children before the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2009, 28(August (8)):711-716.
16. Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R, Perilla MJ, et al. Impact of long-term routine pneumococcal conjugate vaccine use on carriage and invasive disease potential in Native American communities. J Infect Dis 2012; 205(January (2)).
17. Weatherholtz R., Millar E.V., Moulton L.H., Reid R., Rudolph K., Santosham M., et al. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Clin Infect Dis 2010, 50(May (9)):1238-1246.
18. Hanage W.P., Finkelstein J.A., Huang S.S., Pelton S.I., Stevenson A.E., Kleinman K., et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2010, 2(June (2)):80-84. 80.
19. O'Brien K.L., Moulton L.H., Reid R., Weatherholtz R., Oski J., Brown L., et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 2003, 362(Aug (29381)):355-361.
20. Millar E.V., O'Brien K.L., Watt J.P., Bronsdon M.A., Dallas J., Whitney C.G., et al. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Clin Infect Dis 2006, 43(July (11)):8-15.
21. Moulton L.H., O'Brien K.L., Kohberger R., Chang I., Reid R., Weatherholtz R., et al. Design of a group-randomized Streptococcus pneumoniae vaccine trial. Control Clin Trials 2001, 22(August (4)):438-452.
22. Streptococcus laboratory protocol: lysate preparation [Internet] 2008, Centers for Disease Control and Prevention, Atlanta, GA, [updated 08.02.08], available from: http://www.cdc.gov/ncidod/biotech/strep/protocol_emm-type.htm.
23. Feil E.J., Li B.C., Aanensen D.M., Hanage W.P., Spratt B.G. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004, 186(March (5)):1518-1530.
24. Streptococcus pneumoniae multi-locus sequence typing database [Internet] 1998, Imperial College London, London, England, [updated 20.09.09], available from: http://spneumoniae.mlst.net/.
25. Hinds J., Gould K., Witney A., Lambertsen L., Antonio M., Aanensen D., et al. Molecular serotyping of Streptococcus pneumoniae: a microarray-based genomic tool for isolate typing, detection of multiple carriage and surveillance of serotype replacement in vaccine trials [abstract] Abstracts of the 6th international symposium on pneumococci & pneumococcal diseases 2008.
26. Bentley S.D., Aanensen D.M., Mavroidi A., Saunders D., Rabbinowitsch E., Collins M., et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet 2006, 2(March (3)):e31.
27. Park I.H., Park S., Hollingshead S.K., Nahm M.H. Genetic basis for the new pneumococcal serotype, 6C. Infect Immun 2007, 75(September (9)):4482-4489.
28. Jolley K.A., Wilson D.J., Kriz P., McVean G., Maiden M.C. The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol Biol Evol 2005, 22(March (3)):562-569.
29. Simpson E.H. Measurement of diversity. Nature 1949, 163:688.
30. Hunter P.R., Gaston M.A. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol 1988, 26(November (11)):2465-2466.
31. Grundmann H., Hori S., Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 2001, 39(November (11)):4190-4192.
32. Newton R., Hinds J., Wernisch L. Empirical Bayesian models for analysing molecular serotyping microarrays. BMC Bioinfor 2011, 12(March):88.
33. Pai R., Moore M.R., Pilishvili T., Gertz R.E., Whitney C.G., Beall B., et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 2005, 192(December (11)):1988-1995.
34. Johnson A.P., Sheppard C.L., Harnett S.J., Birtles A., Harrison T.G., Brenwald N.P., et al. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England. J Antimicrob Chemother 2003, 52(December (6)):953-960.
35. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008, 197(April (7)):1016-1027.
36. Johnson H.L., Deloria-Knoll M., Levine O.S., Stoszek S.K., Freimanis Hance L., Reithinger R., et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010, 7(October 5 (10)):e1000348.